Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.

Autor: Breen, Christopher T., Fiellin, David A.
Předmět:
Zdroj: Journal of Law, Medicine & Ethics; Summer2018, Vol. 46 Issue 2, p272-278, 7p
Abstrakt: The article discusses the use of buprenorphine in the treatment of opioid use disorder (OUD), referred to as opioid agonist treatment (OAT), particularly following restrictions on methadone in the U.S. by the U.S. Food and Drug Administration (FDA).
Databáze: Complementary Index